Pharmacoevidence (India)

Alternate name: Pharmacoevidence

ROR: 02zaj1j33

OpenAlex ID: I4405284127

Mortality risk reduction with budesonide/glycopyrrolate/formoterol fumarate versus fluticasone furoate/umeclidinium/vilanterol in COPD: a matching-adjusted indirect comparison based on ETHOS and IMPACT

2023 · Daiana Stolz, Erik Hermansson, et al. · Current Medical Research and Opinion · 15

Bulevirtide improves health-related quality of life measured by EQ-5D VAS in patients with chronic hepatitis delta: An exploratory analysis of a Phase 3 trial at 48 weeks

2023 · M. Buti, H. Wedemeyer, et al. · Digestive and Liver Disease · 7

Efficacy of sacituzumab govitecan versus treatment of physician’s choice in previously treated HR+ and HER2− mBC: a meta-analysis of TROPiCS-02 and EVER-132-002 trials

2025 · Oleg Gluz, Binghe Xu, et al. · Therapeutic Advances in Medical Oncology · 6

A Review of the Utilization of Relative Dose Intensity and Dose Delay Factor in Health Technology Appraisals of Oncology Drugs in Solid Tumors

2025 · Anandaroop Dasgupta, Ankita Kaushik, et al. · Advances in Therapy · 3

MSR78 Advancing Systematic Literature Reviews: A Comparative Analysis of Large Language Models (Claude Sonnet 3.5, Gemini Flash 1.5, and GPT-4) in the Automation Era of Generative AI

2024 · P Rai, S Pandey, et al. · Value in Health · 3

PDF

193P Efficacy of sacituzumab govitecan versus treatment of physician’s choice in previously treated hormone receptor-positive/HER2-negative metastatic breast cancer: A meta-analysis of TROPiCS-02 and EVER-132-002 trials

2024 · O. Gluz, B. Xu, et al. · ESMO Open · 3

PDF

Cost-effectiveness modeling of mortality risk reduction comparing two fixed-dose combination triple therapies in moderate-to-very severe chronic obstructive pulmonary disease

2025 · Krishnali Parsekar, Shubhram Pandey, et al. · Journal of Comparative Effectiveness Research · 2

PDF

EE494 AI-Driven Virtual Assistance Interface for Excel-Based Economic Model

2024 · S Pandey, R Kaur, et al. · Value in Health · 2

PDF

MSR57 Transforming Systematic Literature Reviews: Unleashing the Potential of GPT-4: A Cutting-Edge Large Language Model, to Elevate Research Synthesis

2024 · S Attri, R Kaur, et al. · Value in Health · 2

PDF

MSR15 Revolutionizing Systematic Literature Reviews: Harnessing the Power of Large Language Model (GPT-4) for Enhanced Research Synthesis

2024 · R Kaur, P Rai, et al. · Value in Health · 2

PDF

Msr207 Automated Amcp Dossier Development Using a Retrieval-augmented Generation (rag)-based Multi-agent Approach

2026 · Ankita Sood, Gagandeep Kaur, et al. · Value in Health · 1

CO156 Investigating Composite Response Definitions Based on Key Surrogate Markers for Predicting Clinical Outcomes in Primary Biliary Cholangitis: A Systematic Review and Meta-Analysis

2025 · Dilip Makhija, Marvin Rock, et al. · Value in Health · 1

EE500 Global Economic Burden of Retinitis Pigmentosa (RP): A Systematic Literature Review

2024 · S Kumar, S Attri, et al. · Value in Health · 1

PDF

MSR59 Advancing Systematic Literature Reviews: The Integration of AI-Powered NLP Models in Data Collection Processes

2024 · P Rai, R Kaur, et al. · Value in Health · 1

PDF

MSR74 The Use of Matching-Adjusted Indirect Comparison for Oncology Submissions in NICE

2023 · G. Kaur, B. Singh · Value in Health · 1

PDF

Letter to the Editor Regarding “Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Triple Therapy Compared with Other Therapies for the Treatment of COPD: A Network Meta-Analysis”

2023 · Jonathan Marshall, Akanksha Sharma, et al. · Advances in Therapy · 1

PDF

Predictors of 30-day readmission, mortality, and length of stay for hospitalized U.S. patients with Alzheimer’s and related dementias from 2010 to 2015

2023 · Vassiki Sanogo, Ziyan Chen, et al. · Expert Review of Pharmacoeconomics & Outcomes Research · 1

Relationship of Biochemical Response as Surrogate Endpoints with Long-Term Outcomes in Primary Biliary Cholangitis: A Global Systematic Review and Meta-Analysis

2026 · Dilip Makhija, Marvin Rock, et al. · Journal of health economics and outcomes research

PDF

Relationship of Biochemical Response as Surrogate Endpoints with Long-Term Outcomes in Primary Biliary Cholangitis: A Global Systematic Review and Meta-Analysis

2026 · Dilip Makhija, Marvin Rock, et al. · Journal of health economics and outcomes research

Msr4 a Genai-based Visualization Platform for Systematic Literature Review Insights

2026 · Sukriti Sharma, Rajdeep Kaur, et al. · Value in Health Regional Issues

Msr3 a Living Systematic Literature Review Framework for Eu Joint Clinical Assessment: Real-time Pico Simulation Tested in an Oncology Indication

2026 · Sukriti Sharma, Barinder Singh, et al. · Value in Health Regional Issues

Mechanism-based biomarkers for early detection and plaque vulnerability assessment in atherosclerosis

2026 · Diksha Choudhary, Samriddhi Bali, et al. · Biochemical and Biophysical Research Communications

Identifying Minimum Threshold Level of Trial Crossover Rates Yielding Nonsignificant Overall Survival Benefit Associated with Cancer Treatments: A Systematic Literature Review of HTA Submissions

2026 · Anandaroop Dasgupta, Ankita Kaushik, et al. · Journal of health economics and outcomes research

Msr243 Automating Statistical Analysis Plan Development and Demographic Descriptive Analyses in Clinical Trial Data Using Generative Ai

2026 · Ritesh Dubey, Shubhram Pandey, et al. · Value in Health

Msr10 Incorporating Dynamic Drug Pricing in Us Cost-effectiveness Models: a Hypothetical Simulation Study

2026 · Kushagra Pandey, Parampal Bajaj, et al. · Value in Health

Works count: 160

Citation count: 127